Newscenter Media News The ‘reactome’, an AI-powered platform developed by Cambridge and Pfizer, revolutionizes drug design by accurately predicting chemical reactions, streamlining the pharmaceutical development process. Researchers have…
AI-Powered Drug Design: A Leap in Pharmaceutical Innovation